Description

Description

Gvia-M is an oral tablet manufactured by Genix Pharma, combining Vildagliptin 50mg with Metformin 500mg in each tablet, supplied in a pack of 28 tablets. Vildagliptin belongs to a class of medicines known as DPP-4 inhibitors, which work by helping the body produce more of its own insulin in response to meals while also reducing the release of excess sugar from the liver. Metformin, one of the most widely used medicines for type 2 diabetes, works by improving the body’s sensitivity to insulin and reducing the amount of sugar produced and released by the liver. Combining these two mechanisms in one tablet allows for blood sugar management through complementary pathways, often considered when blood sugar levels are not adequately controlled by metformin alone. Gvia-M is intended for use under medical supervision as part of an ongoing diabetes management plan.

Ingredients

Each Gvia-M tablet contains two active ingredients: Vildagliptin at a strength of 50mg, which supports insulin response after meals, and Metformin at a strength of 500mg, which improves insulin sensitivity and reduces liver sugar output. The tablet also includes standard pharmaceutical-grade excipients for binding, coating, and tablet formation, which support consistent dosing and shelf stability without contributing additional therapeutic effect.

Dosage Form

Gvia-M is available as an oral tablet, supplied in a pack of 28 tablets, with each tablet delivering a fixed-dose combination of 50mg Vildagliptin and 500mg Metformin.

Uses

Gvia-M is generally used in the management of type 2 diabetes, particularly for individuals whose blood sugar levels are not sufficiently controlled with metformin alone. By combining two complementary approaches to blood sugar regulation in a single tablet, Gvia-M can help support more consistent blood sugar control while simplifying a treatment routine that might otherwise involve separate tablets. It is generally used alongside diet, physical activity, and regular blood sugar monitoring as part of an overall diabetes care plan directed by a physician.

How to Use

Gvia-M should be taken exactly as directed by a physician, generally with meals to help reduce the likelihood of stomach discomfort and to support more stable blood sugar control around eating. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless specifically advised otherwise. Blood sugar levels should continue to be monitored regularly while on this medicine, and the dose should not be adjusted or the medicine stopped independently, even if blood sugar readings appear stable, without first consulting the prescribing doctor.

Side Effects

Gvia-M may cause side effects in some individuals, including nausea, stomach upset, diarrhea, or a metallic taste, particularly linked to the Metformin component and often more noticeable when starting treatment. Some patients may also experience headache, dizziness, or mild tremor associated with the Vildagliptin component. Less commonly, Metformin-containing medicines have been associated with a rare but serious condition called lactic acidosis, particularly in individuals with kidney or liver problems, so periodic monitoring of kidney function is generally recommended. Any severe, persistent, or unusual symptoms, including excessive tiredness, muscle pain, or difficulty breathing, should be reported to a doctor promptly.

Pregnancy & Breastfeeding

Gvia-M is generally not recommended during pregnancy, as blood sugar management during pregnancy typically requires a different, closely supervised approach, often involving insulin. Its use during breastfeeding should also be discussed with a healthcare provider beforehand, as safety in this context has not been well established for the Vildagliptin component. Women who are pregnant, planning to conceive, or currently breastfeeding should inform their doctor before this medicine is prescribed.

Storage Instructions

Gvia-M tablets should be stored in a cool, dry place, away from direct sunlight, excess heat, and moisture. Keep the tablets in their original packaging until ready for use, and store them securely out of reach of children and pets. Do not use the tablets after the expiry date printed on the pack.

FAQs

Why does Gvia-M combine two different diabetes medicines?
Combining Vildagliptin and Metformin addresses blood sugar control through two complementary mechanisms, often used when metformin alone isn’t sufficient.

Should Gvia-M be taken with food?
Yes, it is generally taken with meals to help reduce stomach discomfort and support more stable blood sugar control.

Does Gvia-M require regular monitoring?
Yes, regular blood sugar checks and periodic kidney function tests are generally recommended while on this medicine.

Can Gvia-M be used during pregnancy?
It is generally not recommended during pregnancy, and a doctor should be informed immediately if pregnancy occurs or is suspected.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.